ATAR (ATAR) Stock Price & Analysis
ATAR (ATAR) rose 0.00% to USD 0 as of June 10, 2026 at 15:08 UTC, according to Nexqual real-time market data.
ATAR last closed at USD 0; the session ranged USD 0–0 on volume of 4,900 shares. Market capitalization is $7,295, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 15:08 UTC.
Key Statistics (as of June 10, 2026 at 15:08 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 4,900 shares |
| Market Cap | $7,295 |
| Exchange | PNK |
Technical Analysis (ATAR)
Nexqual's technical model rates ATAR "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 15:08 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (ATAR)
Wall Street analysts rate ATAR "None", per Nexqual as of June 10, 2026 at 15:08 UTC.
| Consensus Rating | None |
|---|
Earnings (ATAR)
Source: Nexqual, June 10, 2026 at 15:08 UTC.
Financials & Fundamentals (ATAR)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -105.53% |
| Debt / Equity | 6.13 |
| Current Ratio | 1.15 |
| Total Cash | $49 |
| Total Debt | $10,990 |
| Free Cash Flow | $-303,739 |
Source: Nexqual, June 10, 2026 at 15:08 UTC.
Financial Health Score (ATAR)
Nexqual rates ATAR's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 15:08 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Strong — $49 cash, no debt |
| Cash Flow | Weak — Operating cash flow -$305K |
| Efficiency | Critical — ROE -106%, ROA -58.2% |
Ownership (ATAR)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 72.95M |
Source: Nexqual, June 10, 2026 at 15:08 UTC.
Leadership (ATAR)
ATAR is led by Ronald E. Hughes (age 63), CEO, President, Director of Business Development & Director, per Nexqual as of June 10, 2026 at 15:08 UTC.
| CEO, President, Director of Business Development & Director | Ronald E. Hughes (age 63) |
|---|---|
| CFO, Principal Accounting Officer, Treasurer & Secretary | Chen Zhen (age 47) |
| Chief Operating Officer | Peter Martinez |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IPLY | INTERPLAY ENTERTAINMENT CORP | USD 0 | ▲ 0% |
| CCUR | CCUR Holdings, Inc. | USD 2,310 | ▲ 0% |
| GNTA | Genenta Science S.p.A. | USD 1.44 | ▼ 20.28% |
| ACTU | Actuate Therapeutics, Inc. | USD 1.94 | ▲ 6.59% |
| APAC | StoneBridge Acquisition II Corp | USD 10.14 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 15:08 UTC. This page is informational and not investment advice.